Expert Review of Pharmacoeconomics & Outcomes Research
ISSN 1473-7167 · Taylor & Francis · United Kingdom · active 1976–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Expert Review of Pharmacoeconomics & Outcomes Research a predatory journal?
Our screening does not flag Expert Review of Pharmacoeconomics & Outcomes Research. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Expert Review of Pharmacoeconomics & Outcomes Research indexed in Scopus or Web of Science?
Per our venue index, Expert Review of Pharmacoeconomics & Outcomes Research appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Expert Review of Pharmacoeconomics & Outcomes Research's impact?
Papers in Expert Review of Pharmacoeconomics & Outcomes Research are cited about 1.7 times each within two years of publication, and Scimago places it in Q3, with an h-index of 80. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Expert Review of Pharmacoeconomics & Outcomes Research open access?
We hold no reliable open-access classification for Expert Review of Pharmacoeconomics & Outcomes Research. Check the journal's own site for its access model and any article processing charge.